Safety, immunogenicity and efficacy of Relcovax®, a dual receptor binding domain (RBD) and nucleocapsid (N) subunit protein vaccine candidate against SARS-CoV-2 virus by Sathe, Nikhil, Shaikh, Sameer, Bhavsar, Mahesh, Parte, Leena, Gadiparthi, Anjaneyulu, Kad, Satish, Sensarma, Sayandev, Nalband, Hassan, Sangapillai, R., Sivashanmuganathan, S., Pusalkar, Rakhi, Anandan, Sathyavathy, Masand, Girish, Pratapreddy, K., Harinarayana Rao, S., Gokhale, Abhiram, Vidyadhar Reddy, G.E.C., Karanam, Gopala, Phatarphekar, Abhishek, Rao, Praveen, Ramana, Venkata, Ramnath, R.L.

Get full text